|
CCNC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.09270411899843E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.42369482658955E-11 |
| Normal-vs-Stage2 |
4.815600E-04 |
| Normal-vs-Stage3 |
3.952400E-04 |
| Normal-vs-Stage4 |
1.275690E-02 |
| Stage1-vs-Stage2 |
5.444000E-01 |
| Stage1-vs-Stage3 |
4.060600E-01 |
| Stage1-vs-Stage4 |
9.290600E-01 |
| Stage2-vs-Stage3 |
9.152200E-01 |
| Stage2-vs-Stage4 |
7.587000E-01 |
| Stage3-vs-Stage4 |
7.045400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.87270207621759E-11 |
| Normal-vs-AfricanAmerican |
1.79421999999541E-05 |
| Normal-vs-Asian |
8.918400E-02 |
| Caucasian-vs-AfricanAmerican |
6.815900E-02 |
| Caucasian-vs-Asian |
5.789200E-01 |
| AfricanAmerican-vs-Asian |
1.663810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.66130451009872E-11 |
| Normal-vs-Female |
1.62339999998373E-07 |
| Male-vs-Female |
3.941800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.31549999996083E-06 |
| Normal-vs-Extreme_Weight |
4.84690065860605E-12 |
| Normal-vs-Obese |
1.13710000004819E-06 |
| Normal-vs-Extreme_Obese |
4.310100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.953800E-01 |
| Normal_Weight-vs-Obese |
3.890400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.029400E-01 |
| Extreme_Weight-vs-Obese |
1.006170E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.350780E-01 |
| Obese-vs-Extreme_Obese |
9.381800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.27990000000378E-05 |
| Normal-vs-Age(41-60Yrs) |
1.40540001858369E-09 |
| Normal-vs-Age(61-80Yrs) |
9.42930178382539E-11 |
| Normal-vs-Age(81-100Yrs) |
5.41360000050339E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.500400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.231800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.467400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.882000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.782240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.18509979607495E-10 |
| Normal-VS-Type2 PRCC |
8.9411000003814E-07 |
| Normal-VS-KIRP CIMP |
5.387600E-02 |
| Normal-VS-Unclassified PRCC |
2.15719999641095E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.617200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.351600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.808000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.419600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.684400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.736800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19880019641994E-10 |
| Normal-vs-N1 |
4.823100E-03 |
| Normal-vs-N2 |
1.92559999945274E-07 |
| N0-vs-N1 |
5.308100E-02 |
| N0-vs-N2 |
1.036590E-01 |
| N1-vs-N2 |
2.527800E-02 |
|
|
